INTERNATIONAL PATENT: KEYMED BIOSCIENCES (CHENGDU) CO., LTD. FILES APPLICATION FOR "ANTIBODIES TARGETING IL-13 AND TSLP AND USES THEREOF"

GENEVA, Oct. 13 -- KEYMED BIOSCIENCES (CHENGDU) CO., LTD. (Building D2, No. 18, Bio-Town Middle Road, Chengdu Tianfu International Bio-Town, Shuangliu DistrictChengdu, Sichuan 610219) filed a patent application (PCT/CN2025/086669) for "ANTIBODIES TARGETING IL-13 AND TSLP AND USES THEREOF" on Apr 01, 2025. With publication no. WO/2025/209486, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Bo (Building D2, No. 18, Bio-Town Middle Road, Chengdu Tianfu International Bio-Town, Shuangliu DistrictChengdu, Sichuan 610219),...